跳至主要内容
临床试验/NCT07794787
NCT07794787招募中不适用

To Develop and Validate an Equation for Determination of Major Adverse Kidney Events in Patients With Decompensated Cirrhosis and Ascites- A Prospective Cohort Study

Institute of Liver and Biliary Sciences, India2 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2026年8月31日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
400
试验地点
2
主要终点
Major Adverse Kidney Events at 1 year.

研究概览

简要总结

Acute kidney injury (AKI) is the sudden loss of kidney function that occurs frequently in hospitalised patients with cirrhosis.

  • It develops in up to 53% and is independently associated with high short-term mortality.
  • A diagnosis of AKI (even stage 1 AKI) has been shown to be associated with an increased risk of long-term mortality at 30-day, 90-day and 1-year, compared to patients without AKI, even when there is recovery of AKI.
  • Risk factors with the strongest association for developing AKI include CKD, sepsis, spontaneous bacterial peritonitis (SBP), and presence of ascites.
  • AKI in cirrhosis is also associated with development of de-novo chronic kidney disease (CKD) , progressive loss of kidney function in patients with pre-existing CKD,recurrent AKI (i.e., AKI on top of CKD) and other organ failures
  • Kidney dysfunction in patients with cirrhosis is associated with a marked increase in mortality compared with patients without kidney dysfunction.
  • The accurate estimation of kidney function in patients with cirrhosis is hence crucial for prognosis, treatment strategies, and decisions regarding simultaneous liver-kidney transplantation (SLKT).
  • Although measured GFR(mGFR) may be ideal for assessing kidney function, it is costly, time-consuming, and challenging to perform frequently in fluctuating kidney function. Therefore, GFR is most commonly estimated using serum creatinine (sCr)-based or cystatin C (CysC)-based equations

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of cirrhosis with ascites with stable renal functions in last 7 days (variability in gfr < 15 % and no AKI).

排除标准

  • Patients with age <18 or more than 65 years
  • Obstructive uropathy or intrinsic kidney disease
  • Patients with multiorgan failure or requiring mechanical ventilation
  • Patients who had previously undergone Liver or Kidney transplant
  • Patients with missing laboratory measurements within 24 hours of admission
  • Lack of baseline serum creatinine
  • Need of renal replacement therapy
  • Severe comorbid cardiopulmonary diseases or extrahepatic malignancy

研究组 & 干预措施

Cirrhosis with ascites

Patients with cirrhosis and ascites admitted in ILBS.

结局指标

主要结局

Major Adverse Kidney Events at 1 year.

时间窗: 1 year

Make is defined as the composite outcome of ≥25% decline in estimated-glomerular-filtration-rate (eGFR) compared with baseline with the development of de-novo chronic-kidney-disease (CKD) stage ≥3 or CKD progression (≥50% reduction in eGFR compared with baseline or new haemodialysis or death.

次要结局

  • Development of Liver related decompensating events: worsening of ascites, acute Variceal bleed,SBP and non-SBP infections, hepatic encephalopathy,Hepatocellular carcinoma(1 year)
  • Validation and comparision of new equation with known equations of GFR(1 year)
  • Cumulative incidence of AKI and its impact on MAKE(1 year)
  • AKD and CKD development(1 year)
  • Need for Liver transplant or simultaneous liver kidney transplant(1 year)
  • Numbers of hospitalisations(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验